The ascendancy of Viagra and its impact on the drug landscape presents a intricate question for traders. While the early sales statistics were astounding, the exclusivity has expired, leading to a wave of generic alternatives that are chipping away at revenue. Moreover, the sector is facing difficulties related to demographic trends and evolving he